Stem cell research: cutting-edge science or corporate subsidies, courtesy of voters?
By Capitol Weekly,
Capitol Weekly
| 09. 15. 2005
[Quotes CGS's Marcy Darnovsky]
The organizations created to fund stem cell research in California announced
their first grants last week, despite the fact that the money is held up in
lawsuits. But are they rushing to further science or escape politics?
Last fall, voters approved a stem cell initiative, Proposition 71, by a
59-41 percent margin. Ten months later, the $3 billion in bonds voters
approved are tied up in lawsuits by Republican and anti-abortion groups who
oppose embryonic stem cell research.
Yet, in the long-run, the organizations created by Prop. 71--the Independent
Citizen_s Oversight Committee and the California Institute for Regenerative
Medicine--may have more to worry about from their original allies. A
coalition of Democratic skeptics has put forth a message more likely to gain
traction: You can support stem cell research and still oppose the results of
Prop. 71.
"The debate was framed as being a referendum on stem cell research and
whether you support President Bush," said Jesse Reynolds of the Center for
Genetics and Society. "California voters didn_t approve this as a corporate
subsidy."
Reynolds_ message has gotten support in...
Related Articles
By Risa Cromer, The Conversation | 07.17.2026
By Emily Packard Dawson and Lainie Friedman Ross , The Hastings Center for Bioethics | 07.16.2026
Major news outlets recently reported – based on a bioRxiv preprint – that scientists had edited genes in human embryos with “startling precision.” The scientists’ decision to release this work ahead of peer review, coupled with the extensive media coverage...
By Julia Métraux, Mother Jones [cites CGS' Katie Hasson] | 07.07.2026
During his 2015 State of the Union address, then-President Barack Obama announced what he promised would be an ambitious public health project. “Tonight, I’m launching a new Precision Medicine Initiative to bring us closer to curing diseases like cancer and diabetes...
By Emily Baumgaertner Nunn, The New York Times | 06.30.2026
A research program at the National Institutes of Health released the world’s largest database of human genomes and paired them with clinical data, officials announced Tuesday, paving the way for a new era of study in personalized medicine.
The All...